Global Multiplex PCR Assays Market
Medical Equipment

Global Multiplex PCR Assays Market Projected to Reach $2.83 Billion by 2029 at a CAGR of 13.4%

Discover trends, market shifts, and competitive outlooks for the multiplex pcr assays industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Multiplex PCR Assays Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In the recent years, the market size for multiplex pcr assays has seen a swift growth. The market is projected to rise from $1.51 billion in 2024 to $1.72 billion in 2025, making a compound annual growth rate (CAGR) of 13.6%. Factors such as rising instances of infectious diseases, more government funding and support, increased use in clinical diagnostics, growth in genetic testing and personalized medicine, wider application in academic and research sectors, advancements in bioinformatics and data analysis tools, and escalating healthcare expenditure have contributed to the historic period growth.

In the upcoming years, the multiplex pcr assays market is predicted to experience brisk growth, escalating to $2.83 billion by 2029 at a compound annual growth rate (CAGR) of 13.4%. Numerous factors contribute to the growth estimated for the forecast period, such as the expanding application areas, growing necessity for on-point medical diagnosis, advancements in personalized medicine, hike in research and development spending, increasing consciousness about health and preventive healthcare, strong emphasis on precision medicine and rising call for accurate and swift diagnostic tests. The major trends to keep an eye on in this period include integration of next-generation sequencing (NGS), companion diagnostics, advancement in digital PCR technology, automation, and high-throughput systems, portable and point-of-care devices, adaptability and capacity for multiplexing, incorporation of artificial intelligence and machine learning, improved data management and adoption of cloud solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Multiplex PCR Assays Market?

The surge in diagnostic testing requirements is anticipated to boost the multiplex PCR assay market’s expansion in the future. Diagnostic tests are procedures used to verify the presence or non-existence of a particular ailment in an individual. The escalating need for these tests is largely due to the rise in chronic diseases such as cancer and diabetes, necessitating prompt and precise diagnosis for efficacious treatment. The emphasis on preemptive healthcare also promotes periodic testing to uncover potential problems early. Multiplex PCR assays are a boon as they enable the simultaneous identification and examination of several pathogens or genetic markers from a single specimen, elevating the effectiveness and inclusiveness of diagnostic testing. For example, the National Health Service (NHS), a U.K.-based hospital and medical care provider, registered a diagnostic activity in July 2024 that surpassed the pre-pandemic levels of 2023, indicating a 21% surge in tests conducted in May 2024 relative to the same period in the previous year. Furthermore, 2.4 million diagnostic tests were executed in May 2024. Thus, the rising demand for diagnostic testing is set to spur the development of the multiplex PCR assay market.

How Is the Multiplex PCR Assays Market Segmented?

The multiplex pcr assays market covered in this report is segmented –

1) By Assay Type: Planar Assay, Bead Based Assay

2) By Product And Services: Consumables, Instruments, Software And Services

3) By Application: Disease Diagnosis, Research And Development, Other Applications

4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:

1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays

2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp

Which Regions Are Key Players in the Growth of the Multiplex PCR Assays Market?

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Multiplex PCR Assays Market?

Leading firms in the multiplex PCR assays market are placing an emphasis on implementing automated technology, such as next-generation quantitative PCR (qPCR) systems, to offer precise and flexible nucleic acid quantification in advanced clinical diagnostics and public health scenarios. Next-generation qPCR, with its capacity for highly efficient, accurate, and concurrent detection of multiple targets, improves efficiencies and accuracy in diagnostics. For instance, in November 2023, the Switzerland-based Roche Diagnostics Corporation, a major player in diagnostic system solutions, introduced the LightCycler PRO System. This upgraded qPCR platform provides high-throughput, precision, and concurrent detection of numerous targets. It comes with improved temperature uniformity, state-of-the-art software, and interoperability with more than 200 LightMix Modular and 60 CE-IVD assays, enhancing diagnostic accuracy and efficiency. This system embodies how automation is being assimilated into the Multiplex PCR Assays market, propelling advancements in clinical diagnostics and public health.

View the full report here:

https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

How Is the Multiplex PCR Assays Market Defined and What Are Its Core Parameters?

Multiplex PCR assays refer to a type of polymerase chain reaction (PCR) technique that allows simultaneous amplification and detection of multiple DNA or RNA targets within a single reaction. This method enhances efficiency by enabling the analysis of several genetic markers or pathogens in one test, providing comprehensive and cost-effective results.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18681

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model